期刊
RSC MEDICINAL CHEMISTRY
卷 13, 期 5, 页码 599-609出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/d2md00023g
关键词
-
资金
- Council of Scientific and Industrial Research, New Delhi [02/(0354)/19/EMRII]
- SERB DST [ECR/2015/000240, CRG/2020/003257]
- DST
- University Grants Commission
A series of morpholine substituted quinazoline derivatives have been synthesized and evaluated for their cytotoxic potential against several cancer cell lines. Among them, AK-3 and AK-10 showed significant cytotoxic activity against three different cell lines and were found to inhibit cell proliferation in the G1 phase of the cell cycle through apoptosis.
A series of morpholine substituted quinazoline derivatives have been synthesized and evaluated for cytotoxic potential against A549, MCF-7 and SHSY-5Y cancer cell lines. These compounds were found to be non-toxic against HEK293 cells at 25 mu M and hence display anticancer potential. In these series compounds, AK-3 and AK-10 displayed significant cytotoxic activity against all the three cell lines. AK-3 displayed IC50 values of 10.38 +/- 0.27 mu M, 6.44 +/- 0.29 mu M and 9.54 +/- 0.15 mu M against A549, MCF-7 and SHSY-5Y cancer cell lines. Similarly, AK-10 showed IC50 values of 8.55 +/- 0.67 mu M, 3.15 +/- 0.23 mu M and 3.36 +/- 0.29 mu M against A549, MCF-7 and SHSY-5Y, respectively. In the mechanistic studies, it was found that AK-3 and AK-10 inhibit the cell proliferation in the G1 phase of the cell cycle and the primary cause of death of the cells was found to be through apoptosis. Thus, morpholine based quinazoline derivatives have the potential to be developed as potent anticancer drug molecules.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据